SOMATOSTATIN RECEPTOR

Clinical trials for SOMATOSTATIN RECEPTOR explained in plain language.

Never miss a new study

Get alerted when new SOMATOSTATIN RECEPTOR trials appear

Sign up with your email to follow new studies for SOMATOSTATIN RECEPTOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet recruiting 1

Radioactive drug trial seeks to target Hard-to-Treat tumors

Disease control Not yet recruiting

This first-in-human study aims to test the safety and find the right dose of a new radioactive drug called RYZ401 for people with advanced neuroendocrine tumors and other solid tumors. The treatment delivers radiation directly to cancer cells that have specific markers. The study…

Matched conditions: SOMATOSTATIN RECEPTOR

Phase: PHASE1 • Sponsor: RayzeBio, Inc. • Aim: Disease control

Last updated Apr 02, 2026 14:58 UTC

SOMATOSTATIN RECEPTOR

Get alerted when new SOMATOSTATIN RECEPTOR trials appear

Radioactive drug trial seeks to target Hard-to-Treat tumors